Article Information
vol. 31 no. 164
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 22, 2021
- Accepted April 20, 2022
- Published online June 7, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Giovanni Paoletti1,2,
- Jack Pepys2,
- Marta Casini2,
- Danilo Di Bona3,
- Enrico Heffler1,2,
- Celine Y.Y. Goh4,5,
- David B. Price4,5,6 and
- Giorgio Walter Canonica1,2⇑
- 1IRCCS Humanitas Research Hospital, Milan, Italy
- 2Dept of Biomedical Sciences, Humanitas University, Milan, Italy
- 3School and Chair of Allergology and Clinical Immunology, Dept of Emergency and Organ Transplantation, University of Bari Aldo Moro, Bari, Italy
- 4Optimum Patient Care Global, Cambridge, UK
- 5Observational and Pragmatic Research Institute, Singapore, Singapore
- 6Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
- Corresponding author: Giorgio Walter Canonica (giorgio_walter.canonica{at}hunimed.eu)
Article usage
Altmetrics
Vol 31 Issue 164
Table of Contents
Biologics in severe asthma: the role of real-world evidence from registries
Jump To
- Article
- Abstract
- Abstract
- Introduction
- The role of registries in real-life research of severe asthma
- The role of biologics in real life
- The role of the International Severe Asthma Registry
- The role of the Severe Heterogeneous Asthma Research Collaboration, Patient-Centred
- Evidence from RCTs and real-life research is complementary
- Conclusion
- Footnotes
- References
- Figures & Data
- Info & Metrics